Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ACAMPROSATE vs ACETAMINOPHEN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ACAMPROSATE vs ACETAMINOPHEN: Safety Overview

Metric ACAMPROSATE ACETAMINOPHEN
Total FAERS Reports 524 136,761
Deaths Reported 53 30,085
Death Rate 10.1% 22.0%
Hospitalizations 290 50,046
Average Patient Age 51.7 yrs 48.9 yrs
% Female Patients 36.9% 68.3%
FDA Approval Date Jul 16, 2013 Approved Prior to Jan 1, 1982
Manufacturer American Health Packaging Cranbury Pharmaceuticals, LLC
Route ORAL ORAL
Marketing Status Discontinued Discontinued